The topic of the presentation resonates strongly with the growing need for healthcare professionals to consider the reproductive impacts of common medications. Arevik’s research highlights how regulatory standards around medication use vary by country. This work sheds light on the importance of clear and comprehensive guidelines for prescribing drugs that may impact fertility.
The presentation ignited insightful discussions among attendees, highlighting the urgent need for ongoing research in this critical field. In the wake of the conference, plans are underway to broaden this research and collaborate with global experts to delve deeper into the relationship between medication and reproductive health. The ultimate objective is to establish a comprehensive, accessible database that empowers healthcare providers to adopt safer, fertility-conscious prescribing practices.
